Sildenafil citrate in erectile dysfunction in diabetes

Controlled trial of sildenafil citrate (Cupid) in diabetes patients with erectile dysfunction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

SLCTR

Registry ID

SLCTR/2007/011

Enrollment

Registered

2007-09-21

Start date

2006-03-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile dysfunction in diabetes patients

Interventions

Giving sildenafil citrate (Cupid) or placebo

Eligibility

Inclusion criteria

Inclusion criteria: All diabetes patients with erectile dysfunction

Exclusion criteria

Exclusion criteria: Patients taking nitrates for ischemic heart disease

Design outcomes

Primary

Measure	Time frame
Relief of erectile dysfunction []	—

Secondary

Measure	Time frame
Patient and partner satisfaction []	—

Countries

Sri Lanka

Contacts

Public ContactColvin Goonaratna

Professor

colvin_cg@yahoo.com4612643

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 9, 2026